Found 16 matching trials
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Reactivating NK Cells in Treating Refractory Head and Neck Cancer PHASE1 This study aims to determine the safety and efficacy of expanded activated ...
Show More Location
National University Hospital
Learn More & Join Trial
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) PHASE1 To find the highest and/or recommended dose of TROP2-CAR-NK cells combined ...
Show More Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Learn More & Join Trial
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors PHASE1 This is a Phase 1 dose-finding study of FT536 given in combination with a m...
Show More Location
Honor Health Research Institute
Learn More & Join Trial
Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer PHASE1 The aim of this study is the safety and efficacy of Cetuximab plus natural ...
Show More Location
Fuda cancer institute in Fuda cancer hospital
Learn More & Join Trial
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab PHASE1 This study is a Phase 1b open-label study designed to characterize the safe...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors PHASE1 This is a prospective, open-label, exploratory clinical study to evaluate t...
Show More Location
Multiple Locations
Learn More & Join Trial
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC PHASE2 The purpose of this research study is to test the safety and efficacy of th...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers PHASE1 The purpose of the Phase 1/2a study is to evaluate the safety and tolerabil...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment PHASE1 This clinical trial is a Single-Center, Open, Phase I/IIa Clinical Trial co...
Show More Location
Asan Medical Center
Learn More & Join Trial